KETOROLAC TROMETHAMINE INJECTION, USP
JUNO PHARMA CANADA INC.
Quick answers
Is there a shortage of KETOROLAC TROMETHAMINE INJECTION, USP in Canada?
No. There is no current shortage of KETOROLAC TROMETHAMINE INJECTION, USP 30MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ACULAR
ABBVIE CORPORATION
TORADOL IM
ATNAHS PHARMA UK LIMITED
TORADOL
AA PHARMA INC
APO-KETOROLAC
APOTEX INC
MINT-KETOROLAC
MINT PHARMACEUTICALS INC
MAR-KETOROLAC
MARCAN PHARMACEUTICALS INC
DIN
02443376
Strength
30MG
Dosage Form
Solution
Route
Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JUNO PHARMA CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
100MG · DIN 02561557
0.01% · DIN 02529580
100MG · DIN 00821780
100MCG · DIN 02489244
250MCG · DIN 02538377
50MG · DIN 02460947
70MG · DIN 02460955
2MG · DIN 02408813
100MCG · DIN 02467976
400MCG · DIN 02487373
200MCG · DIN 02487365
250MG · DIN 02544083